Effective cancer immunotherapy based on combination of TLR agonists with stimulation of phagocytosis-Reference-Cited by-同舟云学术

Effective cancer immunotherapy based on combination of TLR agonists with stimulation of phagocytosis

Published:2018-06 Issue: Volume:59 Page:86-96
ISSN:1567-5769
Container-title:International Immunopharmacology
language:en
Short-container-title:International Immunopharmacology

Author:

Caisová Veronika,Uher Ondřej,Nedbalová Pavla,Jochmanová Ivana,Kvardová Karolína,Masáková Kamila,Krejčová Gabriela,Paďouková Lucie,Chmelař Jindřich,Kopecký Jan,Ženka Jan

Funder

Research Support Foundation, Vaduz, Fürstentum Liechtenstein

Publisher

Elsevier BV

Subject

Pharmacology,Immunology,Immunology and Allergy

Reference23 articles.

1. The treatment of malignant tumors by repeated inoculations of erysipelas: with a report of ten original cases;Coley;Am. J. Med. Sci.,1893

2. Pathogen recognition and innate immunity;Akira;Cell,2006

3. A current perspective on cancer immune therapy: step-by-step approach to constructing the magic bullet;D'Errico;Clin. Transl. Med.,2017

4. Therapeutic targeting of innate immunity with Toll-like receptor agonists and antagonists;Kanzler;Nat. Med.,2007

5. Toll-like receptor agonists in cancer therapy;Adams;Immunotherapy,2009

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of B cells in intratumoral MBTA immunotherapy of murine pheochromocytoma model;Best Practice & Research Clinical Endocrinology & Metabolism;2024-09

2. Cutaneous Melanoma: An Overview of Physiological and Therapeutic Aspects and Biotechnological Use of Serine Protease Inhibitors;Molecules;2024-08-16

3. Harnessing innate immune pathways for therapeutic advancement in cancer;Signal Transduction and Targeted Therapy;2024-03-25

4. The Immune Landscape of Pheochromocytoma and Paraganglioma: Current Advances and Perspectives;Endocrine Reviews;2024-02-20

5. Molecule engineering strategy of toll-like receptor 7/8 agonists designed for potentiating immune stimuli activation;Chemical Communications;2024